FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest drug approvals
- Alvaiz (eltrombopag choline) - November 29, 2023
- Ogsiveo (nirogacestat) - November 27, 2023
- Ryzneuta (efbemalenograstim alfa-vuxw) - November 16, 2023
- Truqap (capivasertib) - November 16, 2023
- Augtyro (repotrectinib) - November 15, 2023
- DefenCath (taurolidine and heparin) - November 15, 2023
- Adzynma (ADAMTS13, recombinant-krhn) - November 09, 2023
- Ixchiq (chikungunya vaccine, live) - November 09, 2023
- Fruzaqla (fruquintinib) - November 08, 2023
- Zepbound (tirzepatide) - November 08, 2023
- Zituvimet (metformin hydrochloride and sitagliptin) - November 03, 2023
- Voquezna (vonoprazan) - November 01, 2023
- Wezlana (ustekinumab-auub) - October 31, 2023
- Loqtorzi (toripalimab-tpzi) - October 27, 2023
- Agamree (vamorolone) - October 26, 2023
- Omvoh (mirikizumab-mrkz) - October 26, 2023
- Cabtreo (adapalene, benzoyl peroxide and clindamycin phosphate) - October 20, 2023
- Penbraya (meningococcal groups A, B, C, W, and Y vaccine) - October 20, 2023
- Zymfentra (infliximab-dyyb) - October 20, 2023
- Zituvio (sitagliptin) - October 18, 2023